200 TECHNOLOGY SQUARE, CAMBRIDGE, MA
Adds Chief Operating Officer Role as Expands into Oncology
Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes
Financial Results, Press Release
Appoints Michael McDonnell to Board of Directors
Amendments to Articles of Incorporation or Bylaws, Shareholder votes
Reports First Quarter 2026 Financial Results and Provides Business Updates
Annual Report to Security Holders
Moderna Enters $950 Million Settlement Agreement with Arbutus/Genevant
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
SC TO-I
Tender Offer Statement by Issuer
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Tender Offer Statement by Issuer
Submission Upload
Correspondence